Human microglial transitions at the Aβ–tau inflection point associate with divergent pathways to dementia and resilience - Scorecard - MDSpire

Human microglial transitions at the Aβ–tau inflection point associate with divergent pathways to dementia and resilience

  • By

  • Ashley Lu

  • Wei-Ting Chen

  • Maria Dalby

  • Diego Sainz Garcia

  • Marisa Vanheusden

  • Luuk E. de Vries

  • Veerle van Lieshout

  • Araks Martirosyan

  • Katleen Craessaerts

  • Sebastiaan Moonen

  • Magdalena Zielonka

  • Iordana Chrysidou

  • Anke Misbaer

  • Leen Wolfs

  • Benjamin Pavie

  • Dick Swaab

  • Dietmar Rudolf Thal

  • Inge Huitinga

  • Annemieke Rozemuller

  • Susan Karijn Rohde

  • Marc Hulsman

  • Henne Holstege

  • Rita Balice-Gordon

  • Niels Plath

  • Mark Fiers

  • Bart De Strooper

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: Transitions in Human Microglia at the Aβ–tau Intersection Relate to Different Pathways Leading to Dementia and Resilience

At a Glance

CategoryDetail
Condition
Key MechanismsMicroglial modulation at the Aβ–tau interface transition (needs citation)
Target Population
Care Setting

Key Highlights

  • Remove unsupported claims

Guideline-Based Recommendations

Diagnosis

    Management

    • F
    • o
    • c
    • u
    • s
    • o
    • n
    • u
    • n
    • d
    • e
    • r
    • s
    • t
    • a
    • n
    • d
    • i
    • n
    • g
    • i
    • m
    • m
    • u
    • n
    • e
    • r
    • e
    • s
    • p
    • o
    • n
    • s
    • e
    • s
    • a
    • n
    • d
    • m
    • i
    • c
    • r
    • o
    • g
    • l
    • i
    • a
    • l
    • a
    • c
    • t
    • i
    • v
    • a
    • t
    • i
    • o
    • n
    • i
    • n
    • A
    • D
    • p
    • a
    • t
    • h
    • o
    • l
    • o
    • g
    • y
    • (
    • n
    • e
    • e
    • d
    • s
    • c
    • i
    • t
    • a
    • t
    • i
    • o
    • n
    • )

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Older adults, specifically octogenarians and centenarians.

        Resilience mechanisms may provide insights for therapeutic targets.

        Clinical Best Practices

        • Incorporate spatial transcriptomics for detailed pathology assessment (needs citation)

        Related Resources & Content

        Original Source(s)

        Related Content